ArticleDrug design, development and therapy2015
Evaluation of the efficacy and safety of three dosing regimens of agalsidase alfa enzyme replacement therapy was underpowered.
Alberto Ortiz et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.